Showing results 1 to 20 of 85
next >
Title | Author(s) | Issue Date | |
---|---|---|---|
2005 | |||
2014 | |||
Biological Therapy in Hepatocellular Carcinoma Proceeding/Conference:Chinese Society of Hepatology Annual Meeting, Beijing, China | 2016 | ||
Cancer Immunotherapy: Recent Advances and Impact on Survival Proceeding/Conference:1st HKU International Musculoskeletal Tumour Course, Hong Kong | 2017 | ||
Challenges in the Management of Advanced Hepatocellular carcinoma in the Era of Precision Medicine and Immunotherapy Proceeding/Conference:Chinese Society of Hepatology Annual Meeting, Beijing, China | 2016 | ||
2019 | |||
Checkpoint Inhibitors and Tyrosine Inhibitors Post Immunotherapy in the Management of Advanced HCC Proceeding/Conference:Ipsen Hepatocellular carcinoma (HCC) Asia Scientific Meeting, Seoul, South Korea | 2019 | ||
Checkpoint Inhibitors: Taking Off the Brakes in Immune System Proceeding/Conference:State key Laboratory for Liver Research Symposium 2017, Li Ka Shing Faculty of Medicine, The University of Hong Kong | 2017 | ||
2012 | |||
Complications of traditional Chinese/herbal medicines (TCM)-a guide for perplexed oncologists and other cancer caregivers Journal:Supportive Care in Cancer | 2009 | ||
Cytotoxic & Targeted Therapies for GEP-NETs Proceeding/Conference:4th Asia Pacific Neuroendocrine Tumour Society Conference, APNETS 2016 | 2016 | ||
Development of Immunotherapy in Hepatocellular Carcinoma Patients Proceeding/Conference:4th International Hepatobiliary & Pancreatic Diseases Summit Forum, Hangzhou, China | 2018 | ||
Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011 Journal:Journal of Gastroenterology and Hepatology | 2012 | ||
Drug Development in Hepatocellular Carcinoma: Where are We in Asia Proceeding/Conference:3rd International Conference on Phase 1 and Early Phase Clinical Trials, Hong Kong | 2016 | ||
Editorial to “Palbociclib and letrozole in advanced breast cancer” Journal:Translational Cancer Research | 2017 | ||
2013 | |||
2013 | |||
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis Journal:Asian Pacific Journal of Cancer Prevention | 2013 | ||
Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology | 2010 | ||
Emerging Therapies for Advanced Pancreatic Cancer Patients Proceeding/Conference:International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) World Congress 2014, Vienna, Austria | 2014 |